ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


Silence Therapeutics.
204 announcements.
Time Date Ticker Company Announcement
07:00 07-01-2021 SLN Silence Therapeutics PLC
Holdings in Company
11:08 06-01-2021 SLN Silence Therapeutics PLC
Grant of Options
10:08 06-01-2021 SLN Silence Therapeutics PLC
Holding(s) in Company
07:00 06-01-2021 SLN Silence Therapeutics PLC
Board of Directors Appointment
07:00 06-01-2021 SLN Silence Therapeutics PLC
Silence Therapeutics Appoints Craig Tooman as CFO
07:00 05-01-2021 SLN Silence Therapeutics PLC
January Conference Schedule
11:45 04-01-2021 SLN Silence Therapeutics PLC
Holdings in Company
12:28 15-12-2020 SLN Silence Therapeutics PLC
Holding(s) in Company
17:08 04-12-2020 SLN Silence Therapeutics PLC
Additional listing and Total Voting Rights
09:45 03-12-2020 SLN Silence Therapeutics PLC
Director/PDMR Shareholding
09:44 03-12-2020 SLN Silence Therapeutics PLC
Director/PDMR Shareholding
15:44 17-11-2020 SLN Silence Therapeutics PLC
Additional listing and Total Voting Rights
07:00 16-11-2020 SLN Silence Therapeutics PLC
Positive pre-clinical data presented
07:00 02-11-2020 SLN Silence Therapeutics PLC
Silence Therapeutics Appoints Dr. Marie Wikstrm
16:41 29-10-2020 SLN Silence Therapeutics PLC
Second Price Monitoring Extn
16:36 29-10-2020 SLN Silence Therapeutics PLC
Price Monitoring Extension
14:05 16-10-2020 SLN Silence Therapeutics PLC
Director/PDMR Shareholding
13:15 14-10-2020 SLN Silence Therapeutics PLC
Additional listing and Total Voting Rights
15:49 12-10-2020 SLN Silence Therapeutics PLC
Director/PDMR Shareholding
07:00 08-10-2020 SLN Silence Therapeutics PLC
Change to Executive Leadership Team
16:25 06-10-2020 SLN Silence Therapeutics PLC
Additional Listing and Total Voting Rights
07:00 01-10-2020 SLN Silence Therapeutics PLC
Conference Participation
08:59 23-09-2020 SLN Silence Therapeutics
Holding(s) in Company
07:06 23-09-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
07:04 23-09-2020 SLN Silence Therapeutics
Price Monitoring Extension
16:40 22-09-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
16:35 22-09-2020 SLN Silence Therapeutics
Price Monitoring Extension
07:00 14-09-2020 SLN Silence Therapeutics
2020 interim results
07:05 14-09-2020 SLN Silence Therapeutics
Grant of options
07:00 14-09-2020 SLN Silence Therapeutics
Silence Therapeutics announces new CEO
07:01 08-09-2020 SLN Silence Therapeutics
R&D update
07:00 08-09-2020 SLN Silence Therapeutics
Completion of Nasdaq listing
07:00 08-09-2020 SLN Silence Therapeutics
Instructions exchanging ordinary shares for ADSs
17:47 07-09-2020 SLN Silence Therapeutics
Holding(s) in Company
14:18 04-09-2020 SLN Silence Therapeutics
Holding(s) in Company
07:00 03-09-2020 SLN Silence Therapeutics
Silence to Participate in US Investor Conferences
07:00 01-09-2020 SLN Silence Therapeutics
Silence Therapeutics Notice of Results
07:00 21-08-2020 SLN Silence Therapeutics
Silence Therapeutics Files Registration with SEC
17:02 23-07-2020 SLN Silence Therapeutics
Results of EGM
16:29 22-07-2020 SLN Silence Therapeutics
Holding(s) in Company
16:24 22-07-2020 SLN Silence Therapeutics
Holding(s) in Company
07:00 21-07-2020 SLN Silence Therapeutics
Silence Therapeutics to Participate in Conferences
07:00 16-07-2020 SLN Silence Therapeutics
Mallinckrodt Exercise of Options
10:50 02-07-2020 SLN Silence Therapeutics
Holding(s) in Company
07:00 02-07-2020 SLN Silence Therapeutics
Circular and notice of general meeting
12:39 30-06-2020 SLN Silence Therapeutics
Holding(s) in Company
16:55 29-06-2020 SLN Silence Therapeutics
Holding(s) in Company
07:00 23-06-2020 SLN Silence Therapeutics
Business Update
07:00 23-06-2020 SLN Silence Therapeutics
Submission of Registration Statement to the US SEC
07:00 10-06-2020 SLN Silence Therapeutics
Results of AGM
16:33 05-06-2020 SLN Silence Therapeutics
Holding(s) in Company
16:19 01-06-2020 SLN Silence Therapeutics
Additional Listing
16:41 29-05-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
16:36 29-05-2020 SLN Silence Therapeutics
Price Monitoring Extension
09:37 29-05-2020 SLN Silence Therapeutics
PDMR Shareholding
16:28 21-05-2020 SLN Silence Therapeutics
Grant of Share Options
07:00 20-05-2020 SLN Silence Therapeutics
NASDAQ Intention to List
07:00 20-05-2020 SLN Silence Therapeutics
Broker Appointment
07:00 20-05-2020 SLN Silence Therapeutics
Company Update
07:00 14-05-2020 SLN Silence Therapeutics
Participation at RBC Virtual Healthcare Conference
16:12 12-05-2020 SLN Silence Therapeutics
Holding(s) in Company
09:30 12-05-2020 SLN Silence Therapeutics
PDMR Dealing
07:00 07-05-2020 SLN Silence Therapeutics
Notice of AGM
15:28 20-04-2020 SLN Silence Therapeutics
Additional listing - correction
07:00 20-04-2020 SLN Silence Therapeutics
PDMR Dealing and Additional Listing
09:33 17-04-2020 SLN Edison Investment Research Lim
Edison issues update on Silence Therapeutics (SLN)
07:00 16-04-2020 SLN Silence Therapeutics
Silence Therapeutics publication of Annual Report
07:00 14-04-2020 SLN Silence Therapeutics
Final results year ended 31 December 2019
07:00 09-04-2020 SLN Silence Therapeutics
Silence Announces COVID-19 Partnership
07:00 02-04-2020 SLN Silence Therapeutics
Presentation at Conference and Notice of Results
16:12 01-04-2020 SLN Silence Therapeutics
Additional Listing
11:51 31-03-2020 SLN Silence Therapeutics
Holding(s) in Company
15:00 30-03-2020 SLN Silence Therapeutics
Holding(s) in Company
14:55 25-03-2020 SLN Edison Investment Research Lim
Edison issues update on Silence Therapeutics (SLN)
07:00 25-03-2020 SLN Silence Therapeutics
Collaboration with AstraZeneca
07:01 25-03-2020 SLN Silence Therapeutics
R&D Update
16:42 17-03-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
16:36 17-03-2020 SLN Silence Therapeutics
Price Monitoring Extension
12:07 17-03-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
12:02 17-03-2020 SLN Silence Therapeutics
Price Monitoring Extension
12:07 13-03-2020 SLN Silence Therapeutics
Second Price Monitoring Extn
12:02 13-03-2020 SLN Silence Therapeutics
Price Monitoring Extension
13:23 10-03-2020 SLN Silence Therapeutics
Holding(s) in Company
12:24 02-03-2020 SLN Silence Therapeutics
Holding(s) in Company
09:14 19-02-2020 SLN Silence Therapeutics
Holding(s) in Company
07:03 18-02-2020 SLN Silence Therapeutics
Silence to Present at Cowen Health Care Conference
10:00 17-02-2020 SLN Silence Therapeutics
Silence Launches Scientific Advisory Board
15:23 20-01-2020 SLN Silence Therapeutics
Holding(s) in Company
08:37 13-01-2020 SLN Silence Therapeutics
Holding(s) in Company
10:03 09-01-2020 SLN Edison Investment Research Lim
Edison issues initiation on Silence Therapeutics (SLN)
08:43 09-01-2020 SLN Silence Therapeutics
Holding(s) in Company
09:11 08-01-2020 SLN Silence Therapeutics
Holding(s) in Company
10:12 07-01-2020 SLN Silence Therapeutics
Holding(s) in Company
07:00 07-01-2020 SLN Silence Therapeutics
Silence Therapeutics Announces Business Update
07:00 27-12-2019 SLN Silence Therapeutics
Holding(s) in Company
15:31 17-12-2019 SLN Silence Therapeutics
Management Change
07:45 17-12-2019 SLN Silence Therapeutics
Director disclosure
07:45 17-12-2019 SLN Silence Therapeutics
Board changes
09:14 27-11-2019 SLN Silence Therapeutics
Additional Listing
09:23 22-11-2019 SLN Silence Therapeutics
Additional Listing
14:45 13-11-2019 SLN Silence Therapeutics
Holding(s) in Company
15:13 30-10-2019 SLN Silence Therapeutics
Additional Listing
10:25 25-10-2019 SLN Silence Therapeutics
Additional Listing
10:40 14-10-2019 SLN Silence Therapeutics
Holding(s) in Company
07:00 07-10-2019 SLN Silence Therapeutics
Grant of share options
07:00 07-10-2019 SLN Silence Therapeutics
Holdings in Company
17:21 04-10-2019 SLN Silence Therapeutics
Director/PDMR Shareholding and Additional Listing
15:40 03-10-2019 SLN Silence Therapeutics
Director/PDMR Shareholding
17:09 02-10-2019 SLN Silence Therapeutics
Director/PDMR Shareholding
17:09 30-09-2019 SLN Silence Therapeutics
Director/PDMR Shareholding
07:00 24-09-2019 SLN Silence Therapeutics
First research milestone for SLN500
15:19 20-09-2019 SLN Silence Therapeutics
Additional Listing
16:46 16-09-2019 SLN Silence Therapeutics
Additional Listing
07:00 12-09-2019 SLN Silence Therapeutics
Interim results for six months ended 30 June 2019
08:28 27-08-2019 SLN Silence Therapeutics
Holding(s) in Company
10:14 21-08-2019 SLN Silence Therapeutics
Additional Listing
15:15 19-08-2019 SLN Silence Therapeutics
Additional Listing
07:00 15-08-2019 SLN Silence Therapeutics
Notice of Results and R&D day
07:00 13-08-2019 SLN Silence Therapeutics
Additional Listing
16:27 08-08-2019 SLN Silence Therapeutics
Additional Listing
13:38 07-08-2019 SLN Silence Therapeutics
Additional Listing
12:41 06-08-2019 SLN Silence Therapeutics
Additional Listing
07:00 05-08-2019 SLN Silence Therapeutics
Silence Therapeutics appoints J�rgen Wittendorff
16:22 01-08-2019 SLN Silence Therapeutics
Holding(s) in Company
08:19 31-07-2019 SLN Silence Therapeutics
Holding(s) in Company
17:30 30-07-2019 SLN Silence Therapeutics
Additional Listing
07:00 29-07-2019 SLN Silence Therapeutics
Board Appointment
13:33 26-07-2019 SLN Silence Therapeutics
Holding(s) in Company
12:26 25-07-2019 SLN Silence Therapeutics
Holding(s) in Company
08:43 24-07-2019 SLN Silence Therapeutics
Holding(s) in Company
11:27 23-07-2019 SLN Silence Therapeutics
Additional Listing
16:35 19-07-2019 SLN Silence Therapeutics
Price Monitoring Extension
15:13 19-07-2019 SLN Silence Therapeutics
Additional Listing
11:45 18-07-2019 SLN Silence Therapeutics
Silence collaboration with Mallinckrodt
11:46 18-07-2019 SLN Silence Therapeutics
Mallinckrodt to make equity investment in Silence
11:46 16-07-2019 SLN Silence Therapeutics
Holding(s) in Company
14:06 28-06-2019 SLN Silence Therapeutics
Additional Listing
12:09 25-06-2019 SLN Silence Therapeutics
Result of AGM
13:20 24-06-2019 SLN Silence Therapeutics
Holding(s) in Company
14:36 21-06-2019 SLN Silence Therapeutics
Holding(s) in Company
13:36 20-06-2019 SLN Silence Therapeutics
Holding(s) in Company
13:00 20-06-2019 SLN Silence Therapeutics
Holding(s) in Company
09:16 19-06-2019 SLN Silence Therapeutics
Holding(s) in Company
16:37 18-06-2019 SLN Silence Therapeutics
Holding(s) in Company
13:37 18-06-2019 SLN Silence Therapeutics
Holding(s) in Company
12:28 18-06-2019 SLN Silence Therapeutics
Additional Listing
07:00 28-05-2019 SLN Silence Therapeutics
Collaboration with Genomics England
16:46 20-05-2019 SLN Silence Therapeutics
Additional Listing
15:00 14-05-2019 SLN Silence Therapeutics
Additional Listing
07:00 30-04-2019 SLN Silence Therapeutics
Additional Listing
16:55 25-04-2019 SLN Silence Therapeutics
Additional Listing
07:00 25-04-2019 SLN Silence Therapeutics
Silence Therapeutics Announces Board Changes
07:00 18-04-2019 SLN Silence Therapeutics
Silence Therapeutics Publication of Annual Report
07:00 18-04-2019 SLN Silence Therapeutics
Appointment of Chief Financial Officer
11:00 16-04-2019 SLN Silence Therapeutics
Silence Therapeutics Announces Board Change
07:00 16-04-2019 SLN Silence Therapeutics
Silence Therapeutics appoints Head of R&D and CMO
09:09 04-04-2019 SLN Silence Therapeutics
Holding(s) in Company
07:00 27-03-2019 SLN Silence Therapeutics
Silence Therapeutics submits CTA for SLN124
07:00 11-03-2019 SLN Silence Therapeutics
2018 Preliminary Results
07:00 07-03-2019 SLN Silence Therapeutics
Silence to Present at Cowen Healthcare Conference
07:00 05-03-2019 SLN Silence Therapeutics
Notice of Results
15:35 04-03-2019 SLN Silence Therapeutics
Holding(s) in Company
17:24 26-02-2019 SLN Silence Therapeutics
Holding(s) in Company
16:40 01-02-2019 SLN Silence Therapeutics
Second Price Monitoring Extn
16:35 01-02-2019 SLN Silence Therapeutics
Price Monitoring Extension
07:00 15-01-2019 SLN Silence Therapeutics
SLN124 granted Orphan Drug Designation by EMA
07:00 09-01-2019 SLN Silence Therapeutics
Departure of Chief Financial Officer
07:00 19-12-2018 SLN Silence Therapeutics
Silence Therapeutics advances next RNAi medicine
16:35 18-12-2018 SLN Silence Therapeutics
Price Monitoring Extension
07:00 10-12-2018 SLN Silence Therapeutics
Settlement and License Agreement with Alnylam
17:12 12-10-2018 SLN Silence Therapeutics
Results of Placing
10:14 11-10-2018 SLN Silence Therapeutics
PTAB Upholds Silence Patent
07:00 10-10-2018 SLN Silence Therapeutics
New divisional patent and injunction application
14:16 05-10-2018 SLN Silence Therapeutics
Holding(s) in Company
07:00 26-09-2018 SLN Silence Therapeutics
Silence to Present at Healthcare Conference
14:19 21-09-2018 SLN Silence Therapeutics
Additional Listing
07:00 11-09-2018 SLN Silence Therapeutics
Interim results for six months ended 30 June 2018
10:53 30-08-2018 SLN Silence Therapeutics
Holding(s) in Company
10:46 30-08-2018 SLN Silence Therapeutics
Holding(s) in Company
07:00 24-08-2018 SLN Silence Therapeutics
Notice of Results
09:30 20-08-2018 SLN Silence Therapeutics
Silence Therapeutics Announces Board Change
07:00 07-08-2018 SLN Silence Therapeutics
Litigation: patisiran EU MA imminent
15:00 17-07-2018 SLN Silence Therapeutics
Director/PDMR Shareholding
13:00 17-07-2018 SLN Silence Therapeutics
Appoints David Horn Solomon as CEO
07:00 11-07-2018 SLN Silence Therapeutics
Licensee Quark Pharmaceuticals Patient Dosed Ph 3
07:00 21-06-2018 SLN Silence Therapeutics
Silence Strengthens Board and Leadership Team
16:35 18-06-2018 SLN Silence Therapeutics
Price Monitoring Extension
07:00 15-06-2018 SLN Silence Therapeutics
Presents Data on Lead Programme SLN124 at EHA
10:15 04-06-2018 SLN Silence Therapeutics
Silence Therapeutics Announces Leadership Change
07:00 08-01-2018 SLN Silence Therapeutics
Post year end business update
07:00 22-01-2018 SLN Silence Therapeutics
Key European patent granted
11:48 31-01-2018 SLN Silence Therapeutics
Holding(s) in Company
08:58 02-02-2018 SLN Silence Therapeutics
Holding(s) in Company
11:38 02-02-2018 SLN Silence Therapeutics
Grant of share options and restricted stock units
14:27 15-02-2018 SLN Silence Therapeutics
Additional Listing
07:00 20-02-2018 SLN Silence Therapeutics
Notice of Results
15:40 22-02-2018 SLN Silence Therapeutics
Holding(s) in Company
07:00 05-03-2018 SLN Silence Therapeutics
Silence to present at Cowen Health Care Conference
07:00 06-03-2018 SLN Silence Therapeutics
Preliminary results year ended 31 December 2017
07:00 07-03-2018 SLN Silence Therapeutics
Notice of AGM
07:00 26-03-2018 SLN Silence Therapeutics
Silence to Present at Scientific Conferences
07:00 03-04-2018 SLN Silence Therapeutics
Litigation Update (Portugal and US)
17:00 19-04-2018 SLN Silence Therapeutics
Additional Listing
07:00 24-04-2018 SLN Silence Therapeutics
Results of AGM